Zhitong Finance App News, Orient (605116.SH) issued an announcement. Recently, the company received the “Drug GMP Conformity Inspection Notice” (Zhejiang 2025 No. 0267, Zhejiang 2025 No. 0268) issued by the Zhejiang Drug Administration. The scope of inspection and related workshops and production lines: 1. API (mometasone furoate): 806, 863 workshop, A3 production line; 2. API (betamethasone): 802 workshop, BETB production line.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Orient (605116.SH) issued an announcement. Recently, the company received the “Drug GMP Conformity Inspection Notice” (Zhejiang 2025 No. 0267, Zhejiang 2025 No. 0268) issued by the Zhejiang Drug Administration. The scope of inspection and related workshops and production lines: 1. API (mometasone furoate): 806, 863 workshop, A3 production line; 2. API (betamethasone): 802 workshop, BETB production line.